Interview: Christian L Macher, General Manager, AstraZeneca Taiwan
You have been in Taiwan now for ten months. What are the most important characteristics of this market from your perspective, and what surprised you most about Taiwan? Taiwan is…
AstraZeneca Taiwan has a forward vision and the latest innovations as benchmarks; led by General Manager Christian Macher, it has developed a most professional and efficient pharmaceutical team. The company features and promotes a strong business culture by devoting itself to its core competences and unique advantage. It regards people as the core value of the organization and works at creating a ‘Happy at Work’ environment. This environment can develop people’s potentials and enable the company to be ‘The Best’ pharmaceutical company in Taiwan.
AstraZeneca is one of the world’s leading pharmaceutical companies. Backed by a strong research base and extensive manufacturing and commercial skills, the company provides a powerful range of products for seven important areas of healthcare – Gastrointestinal, Cardiovascular, Cancer, Respiratory, Central Nervous System, Pain Control and Infection.
21st Fl., 207, Tun Hwa South RD., Sec.2 Taipei Metro Building, Taipei 106, Taiwan
Telephone:(02)2378-3374
Fax:(02)2377-0913
Website:www.astrazeneca.com.tw
You have been in Taiwan now for ten months. What are the most important characteristics of this market from your perspective, and what surprised you most about Taiwan? Taiwan is…
Yu-Ih Hou, mayor of New Taipei City, introduces the city and highlights its key competitive advantages and strategic direction of growth as Taiwan’s top economic and cultural destination. Over…
Wei-Hong Tseng, founder and chairman of PharmaCore Biotech, introduces the specialized CDMO and its unique capacities to produce high value-added products. As a leading service provider in Taiwan, Tseng goes…
Carol Cheng, chief operating officer of the Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA), gives an update on the current condition of Taiwan’s biopharma environment and speaks about the country’s innovative…
Bach Chen, CEO of Maisense, highlights the innovative new solutions that the company has created in cardiovascular preventative medicine. Their advanced technology, Freescan, is providing an advanced solution to prevent…
Alan Tsai, general manager, and Carson Chen, chief technology officer of iXensor introduce the startup as an innovative player in the point-of-care diagnostics and digital health space. They jointly discuss…
Dr Jan-Mou Lee, founder of FullHope Biomedical, shares his story of how he came to establish his company after a realization about the loss of impact that occurs when critical…
Arthur Kadurin, CEO of Insilico Medicine Taiwan, tells us how artificial intelligence can change drug discovery process using the innovative generative adversarial networks (GANs) approach. AI is the future…
Ed Deng, co-founder and CEO of Health2Sync, a digital health startup specialized in diabetes management, shares how the application is revolutionizing the ability of patients to take control of the…
Tsung-Tsong Wu, minister without portfolio, offers insights into the current state of Taiwan’s biomedical landscape three years after the administration’s Biomedical Industry Innovation Program was put into place to bolster…
Dr Tse Wen Chang, founder of Immunwork, gives an update on the preclinical development process of the company’s revolutionary T-E pharmaceutical products and goes on to give his expert insights…
Dr James Chih-Hsin Yang, director of National Taiwan University Hospital’s department of oncology, speaks about oncology in Taiwan and the role that the NTU network plays in the island’s oncology…
Rongjin Lin, chairman of Center Ventures and Center Laboratories shares his story of how he revived Center Laboratories from the brink of bankruptcy and repositioned the pharmaceutical company to become…
See our Cookie Privacy Policy Here